- Danone (DANOY, Financial) reports strong Q1 2025 performance with sales up +4.3% like-for-like.
- Exceptional growth in China, North Asia & Oceania with +9.9% LFL.
- €192 million share buyback and successful €800 million bond issuance.
Danone (DANOY) has reported a strong first quarter in 2025, with sales reaching €6,844 million, marking a +4.3% increase on a like-for-like basis. The growth was supported by a +1.9% increase in volume/mix and a +2.4% rise in prices across all categories, highlighting the firm's robust health-oriented portfolio.
The company witnessed exceptional performance in its China, North Asia & Oceania sector, which recorded a +9.9% like-for-like growth. This surge was driven by a +10.4% increase in volume/mix, notably in the Infant Milk Formula category, while the Mizone brand continued to perform strongly.
North America recorded solid growth with a +3.7% like-for-like increase, driven by the high demand for High Protein products under the Oikos brand, despite facing temporary challenges in the Coffee Creamers segment.
In Europe, Danone managed a +2.0% like-for-like growth, continuing its positive volume/mix trend for the sixth consecutive quarter, aided by popular brands such as YoPro, Alpro, and Actimel.
By category, Specialized Nutrition saw a +5.3% increase, Waters grew by +4.1%, and Essential Dairy & Plant-based (EDP) rose by +3.7%. The company completed a €192 million share buyback of 2.7 million shares, aimed at mitigating dilution from employee capital initiatives and long-term incentive plans.
Additionally, Danone successfully issued an €800 million bond with an 8-year maturity, further solidifying its financial strength. The company has reaffirmed its 2025 guidance, anticipating like-for-like sales growth between +3% and +5%, with expectations for recurring operating income to grow faster than sales.
